See the DrugPatentWatch profile for Augmentin
Augmentin is manufactured by GlaxoSmithKline (GSK) [1].
What is Augmentin used to treat?
Augmentin is a combination antibiotic used to treat a variety of bacterial infections. It is effective against infections of the ear, nose, and throat, as well as lower respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone and joint infections [2].
How does Augmentin work?
Augmentin contains two active ingredients: amoxicillin and clavulanic acid. Amoxicillin is a penicillin-type antibiotic that kills bacteria. Clavulanic acid protects amoxicillin from being broken down by enzymes produced by some bacteria, making Augmentin effective against a broader range of bacteria than amoxicillin alone [3].
When does Augmentin's patent expire?
Drug patent information, including expiry dates, can be complex and subject to change due to various factors like patent extensions and legal challenges. For the most accurate and up-to-date patent status of Augmentin, consulting a specialized resource like DrugPatentWatch.com is recommended [4].
Who are Augmentin's main competitors?
Augmentin faces competition from other combination antibiotics that also pair a penicillin-type drug with a beta-lactamase inhibitor. Additionally, generic versions of amoxicillin and clavulanic acid are available, offering alternative treatment options for healthcare providers and patients [3][4].
Can generic versions of Augmentin be made?
Yes, generic versions of Augmentin can be manufactured and sold once the relevant patents have expired and regulatory approval has been obtained. The availability of generics can significantly impact pricing and market access [4].